Cite

HARVARD Citation

    Gulhati, P. et al. (2018). Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater. Oncologist. pp. 277-e26. [Online]. 
  
Back to record